BIORESTORATIVE THERAPIES, INC. Other Nonoperating Income (Expense)
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Other Nonoperating Income (Expense) of $5.73 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-05-14
- BIORESTORATIVE THERAPIES, INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was $5.73K, a 359.71% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was $14.11K, a 3909.09% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was $930.00, a 64.31% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. other nonoperating income (expense) for the quarter ending 2025-06-30 was $518.00, a 43.14% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. other nonoperating income (expense) for fiscal 2025 was $17.45K, a 88.43% decline from fiscal 2024.
- BIORESTORATIVE THERAPIES, INC. other nonoperating income (expense) for fiscal 2024 was $150.85K, a 11.09% decline from fiscal 2023.
- BIORESTORATIVE THERAPIES, INC. other nonoperating income (expense) for fiscal 2023 was $169.66K, a 58.43% increase from fiscal 2022.
- BIORESTORATIVE THERAPIES, INC. other nonoperating income (expense) for fiscal 2022 was $107.09K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $5.73K 10-Q · filed 2026-05-14 | $19.84K derived: sum of 2 quarters · filed 2026-05-14 | $20.77K derived: sum of 3 quarters · filed 2026-05-14 | $21.29K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-12-31 | $14.11K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $15.04K derived: sum of 2 quarters · filed 2026-03-26 | $15.56K derived: sum of 3 quarters · filed 2026-03-26 | $17.45K 10-K · filed 2026-03-26 | |
| 2025-09-30 | $930.00 10-Q · filed 2025-11-12 | $1.45K derived: sum of 2 quarters · filed 2025-11-12 | $3.34K 10-Q · filed 2025-11-12 | $3.05K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-06-30 | $518.00 10-Q · filed 2025-08-12 | $2.41K 10-Q · filed 2025-08-12 | $2.12K derived: sum of 3 quarters · filed 2026-05-14 | $2.68K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-03-31 | $1.25K 10-Q · filed 2026-05-14 | $1.89K 10-Q · filed 2025-05-14 | $1.60K derived: sum of 2 quarters · filed 2026-05-14 | $2.16K derived: sum of 3 quarters · filed 2026-05-14 | $3.08K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $352.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $918.00 derived: sum of 2 quarters · filed 2026-03-26 | $1.83K derived: sum of 3 quarters · filed 2026-03-26 | $150.85K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $566.00 10-Q · filed 2025-11-12 | $1.48K derived: sum of 2 quarters · filed 2025-11-12 | $150.50K 10-Q · filed 2025-11-12 | $169.74K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $911.00 10-Q · filed 2025-08-12 | $149.93K 10-Q · filed 2025-08-12 | $169.17K derived: sum of 3 quarters · filed 2025-08-12 | $203.12K derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $149.02K 10-Q · filed 2025-05-14 | $168.26K derived: sum of 2 quarters · filed 2025-05-14 | $202.21K derived: sum of 3 quarters · filed 2025-05-14 | $242.03K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $19.24K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $53.19K derived: sum of 2 quarters · filed 2025-03-28 | $93.00K derived: sum of 3 quarters · filed 2025-03-28 | $169.66K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $33.95K 10-Q · filed 2024-11-12 | $73.76K derived: sum of 2 quarters · filed 2024-11-12 | $150.42K 10-Q · filed 2024-11-12 | $274.80K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $39.81K 10-Q · filed 2024-08-13 | $116.47K 10-Q · filed 2024-08-13 | $240.84K derived: sum of 3 quarters · filed 2024-08-13 | $223.56K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $76.66K 10-Q · filed 2024-06-11 | $201.03K derived: sum of 2 quarters · filed 2024-06-11 | $183.75K derived: sum of 3 quarters · filed 2024-06-11 | ||
| 2022-12-31 | $124.37K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-06-11 | $107.09K derived: sum of 2 quarters · filed 2024-06-11 | $107.09K 10-K/A · filed 2024-06-11 | ||
| 2022-09-30 | -$17.28K 10-Q · filed 2023-11-13 | -$17.28K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |